Incyte | INCY - Market Capitalization

Stock Price
102.76
Daily Change
0.16 0.16%
Monthly
-3.66%
Yearly
37.10%
Q1 Forecast
96.99

Incyte reported $23.69B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 2.33B 402M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
Biogen USD 20.54B 2.13B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Bristol-Myers Squibb USD 118.91B 9.1B Feb/2026
Eli Lilly USD 1.05T 36.63B Feb/2026
Exelixis USD 10.79B 1.79B Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
Incyte USD 16.56B 3.38B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
MacroGenics USD 114M 8M Feb/2026
Merck USD 293.38B 83.74B Feb/2026
Moderna USD 10.09B 581M Sep/2025
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Pfizer USD 147.57B 12.48B Feb/2026
PTC Therapeutics USD 4.88B 1B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025